Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1139369

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 April 2019 to Question 236381, what steps NHS England has taken to fill the gap left by the closure of the Commissioning Support Programme for those treatments that are awaiting review by the Clinical Priorities Advisory Group.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277724
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>NHS England does not believe that the closure of the Commissioning Support Programme will leave a gap in the review of treatments.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme, undertaken by the National Institute for Health and Care Excellence (NICE), except where there is a clear rationale not to do so. NICE expects to implement this expansion from April 2020. It will be in a position to start progressing topics through the NICE topic selection process from the summer of 2019.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage as for all topics, post stakeholder testing. These are now being progressed though the usual development process. This process is set out in ‘Methods: National Clinical Policies’ at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p>The voluntary scheme agreed between Department and the Association of the British Pharmaceutical Industry on getting the best value and most effective medicines into use more quickly for branded medicines pricing and access was published in November 2018. The voluntary scheme started on 1 January 2019 and will be in place for five years until 2023.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277725 question first answered 23/07/2019 16:50:58 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1139370

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the closure of the Commissioning Support Programme on treatments within NHS England’s Clinical Commissioning Policy programme; and if he will make a statement.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277725
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>NHS England does not believe that the closure of the Commissioning Support Programme will leave a gap in the review of treatments.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme, undertaken by the National Institute for Health and Care Excellence (NICE), except where there is a clear rationale not to do so. NICE expects to implement this expansion from April 2020. It will be in a position to start progressing topics through the NICE topic selection process from the summer of 2019.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage as for all topics, post stakeholder testing. These are now being progressed though the usual development process. This process is set out in ‘Methods: National Clinical Policies’ at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p>The voluntary scheme agreed between Department and the Association of the British Pharmaceutical Industry on getting the best value and most effective medicines into use more quickly for branded medicines pricing and access was published in November 2018. The voluntary scheme started on 1 January 2019 and will be in place for five years until 2023.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277724 question first answered 23/07/2019 16:50:58 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1139371

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to include women who are at risk of contracting HIV in the PrEP impact trial.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277726
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>Women at high risk of contracting HIV are already eligible to participate in the Pre-Exposure Prophylaxis Impact Trial.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 23/07/2019 16:43:55 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1139372

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sophie Holman
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what response his Department has provided to the Prevention of Future Deaths report on the death of Sophie Holman.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277727
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>The Department responded to the Prevention of Future Deaths Report issued by the Assistant Coroner for the Eastern Area of Greater London following the inquest into the death of Sophie Holman on 24 April 2019.</p><p>Publication of the Department’s response is a matter for the Chief Coroner as set out in Coroners (investigations) Regulations 2013.</p><p>The Government is committed to doing all it can to ensure the National Health Service learns from tragic, avoidable deaths and provides high quality, safe care for all patients. This is demonstrated by publication of the NHS Patient Safety Strategy on 2 July 2019. The strategy provides a framework for patient safety improvement over the next 10 years and sits alongside the NHS Long Term Plan.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 23/07/2019 16:04:26 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

1139373

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking in response to the death of Ella Kissi-Debrah to (a) improve asthma care and (b) monitor and reduce the effect of air pollution on asthma outcomes.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277728
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The National Health Service is working closely with voluntary sector partners to improve patient outcomes for those with severe asthma and an NHS Cardiovascular Disease-Respiratory national programme has been developed in line with recommendations from the Taskforce for Lung Health.</p><p>Both respiratory disease and the health of children and young people are priority areas in the NHS Long Term Plan, which aims to improve respiratory care through earlier diagnosis and increased access to treatments. The Respiratory Delivery Board will take forward respiratory proposals set out in the Plan, while the Children’s Transformation Board will oversee work to review national asthma policy and existing clinical guidelines.</p><p>The current quality outcomes framework indicators for asthma are in consultation and changes for the annual review indicators may include data on asthma control; exacerbations; and written personalised action plans. NHS RightCare will be publishing an asthma toolkit later this year to support local commissioners and systems in delivering quality care. A best practice tariff for asthma, which aims to reduce variation in asthma care, is also in development.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:14:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1139376

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that asthma sufferers are referred for specialist treatment.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277729
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>It is expected that National Health Service patients with severe asthma are referred to their specialist asthma service where they will receive appropriate investigation and treatment. All specialised providers are required to develop a networked model of care as the vehicle for delivering an optimal pathway and maximising patient outcomes and experience. All specialised services report against national quality metrics for severe asthma services on an annual basis. Commissioner action is initiated with individual hospitals to address significant issues.</p><p>The NHS England Specialised Commissioning team is running a severe asthma collaborative project to improve patient experience, outcomes and safety through improved access to specialist multidisciplinary teams for assessment and review.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277748 question first answered 26/07/2019 11:22:50 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1139377

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 June 2019 to Question 257660 on Asthma: Health Services, what assessment he has made of the effectiveness of NHS treatment for people with severe asthma.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277730
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The NHS Long Term Plan has committed to improving outcomes for those with respiratory disease in England to match, or exceed, our international counterparts. To achieve this, the National Health Service is working closely with voluntary sector partners to improve patient outcomes for those with severe asthma and an National Health Service Cardiovascular Disease-Respiratory national programme has been developed in line with recommendations from the Taskforce for Lung Health.</p><p>The NHS England Specialised Commissioning team is running a severe asthma collaborative project to improve patient experience, outcomes and safety through improved access to specialist multidisciplinary teams for assessment and review. All specialised providers are required to develop a networked model of care as the vehicle for delivering an optimal pathway and maximising patient outcomes and experience. All specialised services report against national quality metrics for severe asthma services on an annual basis. Commissioner action is initiated with individual hospitals to address significant issues.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:10:56 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1139378

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase the number of severe asthma centres.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277731
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>There are currently 14 severe asthma centres in England. There are no plans to increase the number of centres, as severe asthma collaborative networks will improve severe asthma care within localities. All specialist providers are required to develop a networked model of care as the vehicle for delivering an optimal pathway and maximising patient outcomes and experience.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:11:44 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1139379

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Beta Agonists: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to monitor the safety of the prescription of short-acting beta agonists.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277732
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The Medicines and Healthcare products Regulatory Agency is responsible for monitoring the safety of all healthcare products in the United Kingdom, including short-acting beta agonists and oral corticosteroids to treat asthma. They receive information about safety issues from patients and clinicians through the Yellow Card Scheme. They review the product if necessary and take action to minimise risk and maximise benefit to the patients. Decisions about prescribing rest with the doctor or other prescriber who has clinical responsibility for the particular aspect of a patient’s care.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277733 question first answered 26/07/2019 11:12:37 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1139380

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Steroid Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to monitor the safe prescription of oral corticosteroids to treat asthma.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	277733
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The Medicines and Healthcare products Regulatory Agency is responsible for monitoring the safety of all healthcare products in the United Kingdom, including short-acting beta agonists and oral corticosteroids to treat asthma. They receive information about safety issues from patients and clinicians through the Yellow Card Scheme. They review the product if necessary and take action to minimise risk and maximise benefit to the patients. Decisions about prescribing rest with the doctor or other prescriber who has clinical responsibility for the particular aspect of a patient’s care.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277732 question first answered 26/07/2019 11:12:38 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon